Molecular Pathogenesis and Treatment of Cell Lymphomas
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 4441
Special Issue Editor
Special Issue Information
Dear Colleagues,
T cell lymphomas (TCLs) are highly heterogeneous tumors, displaying distinct clinical and biological features. T-cell lymphomas can develop in lymphoid tissues such as lymph nodes and spleen, or outside of lymphoid tissues (i.e., gastrointestinal tract, liver, nasal cavity, skin, and others). A similar lymphocyte called a natural killer (NK) cell shares many features with T cells. When NK cells become cancerous, the cancer is called NK or NK/T-cell lymphoma and is generally grouped with other T-cell lymphomas.
The aim of this Special Issue is to report original research articles and reviews on any aspect of TCL, including critical signaling pathways, host immune responses, pathogenesis, and novel targeted therapies such as chemotherapy, immunotherapy, stem cell transplant, monoclonal antibodies, nucleoside analogs, protease inhibitors and signaling inhibitors .Research on the deregulation of signaling pathways controlling T-cell development, differentiation, and maturation; the remodeling of the peritumor microenvironment; and the virus-mediated rewiring of T-cell biology is highly welcomed.
Dr. Daniele Caracciolo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- T-cell lymphomas
- natural killer (NK) cell
- gene expression profiling
- gene mutations
- tumor microenvironment
- signaling pathways
- target therapies
- chemotherapy
- immunotherapy
- stem cell transplant
- monoclonal antibodies
- nucleoside analogs
- protease inhibitors
- signaling inhibitors
- CAR-T cells
- T-cell acute lymphoblastic leukaemia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.